Joi + Blokes acquires HerMD for US virtual care

Joi + Blokes acquires HerMD, creating a virtual women’s health platform serving all 50 US states after HerMD’s shift to online-only care in spring 2025.

HerMD relaunched as a virtual-only platform in spring 2025 after closing its physical sites in March 2025. Financial terms were not disclosed. The company had previously raised about US$30m, including a US$18m Series A extension in 2023.

Through the deal, HerMD patients gain access to additional options including peptide therapy and testosterone, preventative lab diagnostics, 30 to 60 minute appointment times and the chance to join research. Peptide therapy uses short chains of amino acids under clinical supervision. Testosterone is a hormone sometimes prescribed for symptoms such as low libido, subject to assessment.

Joi + Blokes says it will add expanded sexual health treatments across the combined service.

The company has treated more than 50,000 patients across all 50 US states. Its model centres on one-to-one visits with clinicians focused on hormonal health, personalised pathways and high reported satisfaction. In a recent survey, 74 per cent of patients said they had sustained improvement.

HerMD was founded by Dr Somi Javaid and Komel Caruso, and has focused on menopause and sexual health advocacy, treatment protocols and patient education. As part of the integration, HerMD will lead a patient education initiative within Joi + Blokes, including a forthcoming Joi x HerMD educational series.

Joi + Blokes was founded by Josh and Katy Whalen and is based in Nashville, Tennessee.